Olanzapine for treatment and prevention of acute chemotherapy‐induced vomiting in children: A retrospective, multi‐center review

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|3|496-501

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.3, 2015-03, pp. : 496-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy-Induced Nausea and Vomiting in the Treatment of Gastrointestinal Tumors and Secondary Prophylaxis with Aprepitant

By  

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 30-34

Karger

Access to resources Recommend Favorite

QoL evaluation of olanzapine for chemotherapy‐induced nausea and vomiting comparing with 5‐HT3 receptor antagonist

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 3, 2015-05 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

State of the art review: Chemotherapy‐induced cardiotoxicity in children

By  

CONGENITAL HEART DISEASE, Vol. 13, Iss. 1, 2018-01 ,pp. : 5-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysis

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : E442-E454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does previous chemotherapy‐induced nausea and vomiting predict postoperative nausea and vomiting?

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 9, 2015-10 ,pp. : 1145-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite